This agrees with the fact that the FLI1 wild type is not expressed in Ewing sarcoma cells [12] and, therefore, targeting the exons of FLI1 that are not included in the EWSR1–FLI1 fusion protein are expected to have no effect. Here, EWSR1 is linked to Ewing sarcoma.